Company Aier Eye Hospital Group Co., Ltd.
Stocks
300015
CNE100000GR6
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.410 CNY | +1.94% |
|
-4.43% | -23.41% |
| 03:02am | Aier Eye Hospital to Acquire Brazilian Eye Care Firms | MT |
| 06-08 | Clínica Baviera, the copy-paste machine |  |
Business description: Aier Eye Hospital Group Co., Ltd.
Number of employees: 42,817
Sales by Activity: Aier Eye Hospital Group Co., Ltd.
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Medical Industry | 14.97B | 16.07B | 20.31B | 20.91B | 22.28B |
Unallocated Other Business | 27.91M | 41.12M | 54.3M | 72.83M | 71.58M |
Geographical breakdown of sales: Aier Eye Hospital Group Co., Ltd.
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
China | - | - | - | - | 19.3B |
Europe | 1.32B | 1.41B | 1.72B | 2.03B | 2.43B |
Southeast Asia | 195M | 308M | 368M | 396M | 433M |
Other | - | - | - | - | 191M |
United States | 57.86M | 58.52M | 48.66M | 44.91M | - |
Intersegment Elimination | -2.53B | -2.71B | -3.59B | -3.67B | - |
Unallocated Amount | 2.53B | 2.71B | 3.59B | 3.67B | - |
Hong Kong | 139M | 158M | 175M | 153M | - |
North-West Region | 490M | 499M | 871M | 902M | - |
Southwest Region | 1.96B | 2B | 2.59B | 2.72B | - |
South China | 1.86B | 2.13B | 2.6B | 2.7B | - |
Northern China | 1.06B | 1.17B | 1.57B | 1.66B | - |
Northeast China | 1.11B | - | 1.79B | 1.75B | - |
East China | 2.08B | 2.31B | 3.11B | 3.32B | - |
Central China | 4.73B | 6.06B | 5.53B | 5.29B | - |
Executive Committee: Aier Eye Hospital Group Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Li Li
CEO | Chief Executive Officer | 61 | 2007-11-30 |
Shi Bo Tang
PSD | President | 65 | - |
Qi Wen Mo
DFI | Director of Finance/CFO | 47 | 2025-11-26 |
Shi Jun Wu
SEC | Corporate Secretary | 54 | 2013-03-31 |
Zhong Han
DFI | Director of Finance/CFO | 61 | 2007-11-30 |
Composition of the Board of Directors: Aier Eye Hospital Group Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Bang Chen
CHM | Chairman | 61 | 2007-11-30 |
Li Li
BRD | Director/Board Member | 61 | 2007-11-30 |
Zhong Han
BRD | Director/Board Member | 61 | 2007-11-30 |
Shi Jun Wu
CHM | Chairman | 54 | 2007-11-30 |
Su Hua Tian
BRD | Director/Board Member | 57 | 2025-11-24 |
Duan Liu
BRD | Director/Board Member | 48 | 2025-11-26 |
Kuo lei Kao
BRD | Director/Board Member | 48 | 2022-11-29 |
Jianjun Zhou
BRD | Director/Board Member | 56 | 2025-11-26 |
Holdings: Aier Eye Hospital Group Co., Ltd.
| Name | Stocks | % | Valuation |
|---|---|---|---|
CLÍNICA BAVIERA, S.A. 73.23% | 11,942,240 | 73.23% | 808 M $ |
ISEC HEALTHCARE LTD. 59.61% | 343,173,790 | 59.61% | 86 M $ |
Company details: Aier Eye Hospital Group Co., Ltd.
Hospitals, Clinics & Primary Care Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.94% | -4.43% | -32.56% | -57.48% | 11.32B | |
| 0.00% | -1.03% | +25.83% | +51.31% | 18.82B | |
| +0.05% | +2.44% | +22.76% | +72.39% | 12.81B | |
| +0.74% | +4.12% | -12.95% | +63.75% | 10.25B | |
| +0.53% | -7.15% | +2.06% | +63.27% | 8.79B | |
| -0.56% | -1.65% | -15.96% | -37.74% | 8.69B | |
| 0.00% | +6.32% | +26.97% | +248.18% | 7.84B | |
| -1.42% | 0.00% | -21.51% | - | 6.38B | |
| -0.81% | +4.73% | +2.53% | -33.93% | 6.2B | |
| -1.12% | 0.00% | - | - | 5.03B | |
| Average | -0.07% | +0.28% | -0.31% | +46.22% | 9.61B | |
| Weighted average by Cap. | +0.10% | -0.08% | +2.70% | +45.55% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 300015 Stock
- Company Aier Eye Hospital Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
